VitalCare Diabetes Treatment Centers Hires Public Relations Firm
View PDF | Print View
by: Dr. Marc Rose
Total views: 10
Word Count: 547
Carson City, NV - VitalCare Diabetes Treatment Centers, Inc. (Pinksheets: VDTI.PK - News), hires Event Management Services, Inc.,(EMSI), a National Public Relations Firm to spread the word of its diabetes treatment breakthrough known as Intracellular Activation Therapy (iCAT).
“We are very excited to have an opportunity to share this breakthrough with the world and offer diabetics a chance to live a more normal and healthier life,” says Dr. Marc Rose, President and Co-founder of VitalCare Diabetes Treatment Centers.
VitalCare Diabetes Treatment Centers and its affiliates provide the iCAT Therapy using the FDA approved micro-dose pulsatile insulin pump, to treat Type 1 and Type 2 diabetics by mimicking the normal function of the pancreas to trigger a more normal liver function, this way optimal food fuels are utilized (glycogen instead of fat) and thus intracellular energy and function returns to optimal levels within each cell within the body. Dr. Rose says that over time, iCAT Therapy helps to stabilize and potentially reverses the secondary complications from diabetes. To date, after more than twenty years of research, no negative reactions or side effects have been reported.
Currently, there are over 25 locations here in the US offering the iCAT treatment, with approximately half of the clinics dedicated to research in Florida, Puerto Rico, Nevada and Texas. VitalCare Diabetes Treatment Centers is working with two centers, one in Arizona and another in Utah, with plans on opening more locations in the near future.
“It is an honor to be a part of spreading the word about this kind of medical breakthrough that could help improve the quality of life to so many people,” says Marsha Friedman, owner of Event Management Services Incorporated. “In our 20 years in business, we have been fortunate enough to create performance based publicity campaigns for many revolutionary thinkers. This campaign (focusing on diabetes) will be especially rewarding because diabetes affects so many lives.”
“We have developed a way to keep diabetics from having to face the otherwise inevitable breakdown of their bodies,” says Dr. Marc Rose. “What a true gift, that we are now poised to share this advancement with the world.”
EMSI will host weekly specials, “Ask the Doctor”, on live talk radio programming, featuring Dr. Marc Rose and other distinguished guests, to educate the public on the services provided by VitalCare Diabetes Treatment Centers and its affiliates. Through the assistance of EMSI, VitalCare will continue its efforts in spreading the good news of this medical breakthrough.
Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.'s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.'s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare's filings with the Securities and Exchange Commission.
About the Author
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on the emerging and FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as "Intracellular Activation Therapy (iCAT)." The World Health Organization (WHO) estimates that more than 180 million people worldwide have diabetes. According to the WHO, this number is likely to more than double by 2030 with diabetes related deaths projected to increase by more than 50% in the next 10 years without urgent action. The US Center for Disease Control, 2005 National Diabetes Fact Sheet, reports the total prevalence of Diabetes in the US for all ages is 20.8 million of which 14.6 million are diagnosed and 6.2 million are undiagnosed.
Rating:
Not yet rated
Comments
No comments posted.
Add Comment
You do not have permission to comment. If you
log in, you may be able to comment.